128 related articles for article (PubMed ID: 9756547)
1. Differential catecholamine responses to protein intake in healthy and hypertensive subjects.
Kuchel O
Am J Physiol; 1998 Oct; 275(4):R1164-73. PubMed ID: 9756547
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic abnormalities in hypertension associated with moderate renal insufficiency.
Kuchel OG; Shigetomi S
Hypertension; 1994 Jan; 23(1 Suppl):I240-5. PubMed ID: 8282367
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic abnormalities in borderline essential hypertensive patients.
Shigetomi S; Buu NT; Kuchel O
Hypertension; 1991 Jun; 17(6 Pt 2):997-1002. PubMed ID: 1904403
[TBL] [Abstract][Full Text] [Related]
4. [Determination of free and conjugated catecholamines, 3,4-dihydroxyphenylalanine, 3,4-dihydroxyphenylacetic acid in the urine and blood plasma by high pressure liquid chromatography].
Kogan BM; Drozdov AZ; Man'kovskaia IV; Filatova TS
Klin Lab Diagn; 1995; (3):25-8. PubMed ID: 8689050
[TBL] [Abstract][Full Text] [Related]
5. Simultaneous measurement of urinary and plasma norepinephrine, epinephrine, dopamine, dihydroxyphenylalanine, and dihydroxyphenylacetic acid by coupled-column high-performance liquid chromatography on C8 and C18 stationary phases.
Benedict CR
J Chromatogr; 1987 Jan; 385():369-75. PubMed ID: 3104375
[TBL] [Abstract][Full Text] [Related]
6. Hormonal correlates of the inadequate natriuretic response to salt loading in idiopathic edema.
Kuchel O; Buu NT; Racz K; Gutkowska J
Clin Invest Med; 1987 Mar; 10(2):71-7. PubMed ID: 3555912
[TBL] [Abstract][Full Text] [Related]
7. Heart failure, aging, and renal synthesis of dopamine.
Ferreira A; Bettencourt P; Pestana M; Correia F; Serrão P; Martins L; Cerqueira-Gomes M; Soares-Da-Silva P
Am J Kidney Dis; 2001 Sep; 38(3):502-9. PubMed ID: 11532681
[TBL] [Abstract][Full Text] [Related]
8. Effects of carbidopa and of intravenous saline infusion into normal and hypertensive subjects on urinary free and conjugated dopamine.
Stokes GS; Monaghan JC; Pillai DN
J Hypertens; 1997 Jul; 15(7):761-8. PubMed ID: 9222944
[TBL] [Abstract][Full Text] [Related]
9. Alternative catecholamine pathways after tyrosine hydroxylase inhibition in malignant pheochromocytoma.
Kuchel O; Buu NT; Edwards DJ
J Lab Clin Med; 1990 Apr; 115(4):449-53. PubMed ID: 1969915
[TBL] [Abstract][Full Text] [Related]
10. CSF and plasma concentrations of free norepinephrine, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), 3,4-dihydroxyphenylalanine (DOPA), and epinephrine in Parkinson's disease.
Eldrup E; Mogensen P; Jacobsen J; Pakkenberg H; Christensen NJ
Acta Neurol Scand; 1995 Aug; 92(2):116-21. PubMed ID: 7484057
[TBL] [Abstract][Full Text] [Related]
11. Defective 3,4-dihydroxyphenylalanine decarboxylation to dopamine in hydralazine-treated hypertensive patients may be pyridoxine remediable.
Shigetomi S; Kuchel O
Am J Hypertens; 1993 Jan; 6(1):33-40. PubMed ID: 8427659
[TBL] [Abstract][Full Text] [Related]
12. Age dependence of the levels of plasma norepinephrine, aldosterone, renin activity and urinary vanillylmandelic acid in normal and essential hypertensives.
Abd-Allah NM; Hassan FH; Esmat AY; Hammad SA
Biol Res; 2004; 37(1):95-106. PubMed ID: 15174309
[TBL] [Abstract][Full Text] [Related]
13. An increase in urinary catecholamines of renal origin in patients with "borderline" hypertension.
Kuchel O; Cuche JL; Buu NT; Genest J
Am J Med Sci; 1976; 272(3):263-8. PubMed ID: 1015511
[TBL] [Abstract][Full Text] [Related]
14. Defective dopamine generation from dihydroxyphenylalanine in stable essential hypertensive patients.
Kuchel O; Shigetomi S
Hypertension; 1992 Jun; 19(6 Pt 2):634-8. PubMed ID: 1592460
[TBL] [Abstract][Full Text] [Related]
15. Inverse relationship between plasma epinephrine and testosterone levels during acute glucoprivation in healthy men.
Elman I; Goldstein DS; Adler CM; Shoaf SE; Breier A
Life Sci; 2001 Mar; 68(16):1889-98. PubMed ID: 11292066
[TBL] [Abstract][Full Text] [Related]
16. The effect of mental stress on catecholamines, their metabolites and plasma renin activity in patients with essential hypertension and in healthy subjects.
Januszewicz W; Sznajderman M; Wocial B; Feltynowski T; Klonowicz T
Clin Sci (Lond); 1979 Dec; 57 Suppl 5():229s-231s. PubMed ID: 396071
[TBL] [Abstract][Full Text] [Related]
17. The heterogeneity of dopamine involvement in essential hypertension.
Kuchel O
Clin Exp Hypertens A; 1989; 11 Suppl 1():217-25. PubMed ID: 2663248
[TBL] [Abstract][Full Text] [Related]
18. Excretion of catecholamines and metabolites in response to increased dietary phosphate intake.
Berndt TJ; MacDonald A; Walikonis R; Chinnow S; Dousa TP; Tyce GM; Knox FG
J Lab Clin Med; 1993 Jul; 122(1):80-4. PubMed ID: 8320494
[TBL] [Abstract][Full Text] [Related]
19. Dissociation of 24-hour catecholamine levels from blood pressure in older men.
Stern N; Beahm E; McGinty D; Eggena P; Littner M; Nyby M; Catania R; Sowers JR
Hypertension; 1985; 7(6 Pt 1):1023-9. PubMed ID: 4077217
[TBL] [Abstract][Full Text] [Related]
20. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
Richards AM; Crozier IG; Espiner EA; Ikram H; Yandle TG; Kosoglou T; Rallings M; Frampton C
J Cardiovasc Pharmacol; 1992; 20(5):735-41. PubMed ID: 1280735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
